Stockscreener 앱 받기
8.20
7.13%
-0.63
시장 영업 전:
8.17
-0.03
-0.37%
Neogenomics Inc (NEO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
0.44%
156.24
|
155.55 | 151.95 | 146.92 | 137.22 |
| Cost Of Revenue |
3.19%
90.77
|
87.96 | 89.64 | 87.03 | 82.41 |
| Gross Profit |
3.14%
65.47
|
67.59 | 62.31 | 59.89 | 54.81 |
Operating Expenses
|
11.46%
96.04
|
86.16 | 86.51 | 89.78 | 89.89 |
| Interest Income/Expense |
87.73%
1.685
|
13.74 | -2.84 | -2.524 | -1.467 |
| Benefits Costs and Expenses |
7.66%
183.92
|
170.84 | 173.41 | 173.56 | 170.94 |
| Costs And Expenses |
7.66%
183.92
|
170.84 | 173.41 | 173.56 | 170.94 |
| Operating Income/Loss |
64.57%
-30.57
|
-18.57 | -24.20 | -29.89 | -35.07 |
| Income/Loss From Continuing Operations Before Tax |
81.09%
-27.68
|
-15.29 | -21.45 | -26.64 | -33.72 |
| Income Tax Expense/Benefit |
35.42%
-0.62
|
-0.96 | -2.935 | -2.309 | -2.925 |
| Income/Loss From Continuing Operations After Tax |
88.89%
-27.06
|
-14.33 | -18.52 | -24.33 | -30.80 |
|
Net Income/Loss
|
88.89%
-27.06
|
-14.33 | -18.52 | -24.33 | -30.80 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
87,477%
126.11
|
0.144 | 125.69 | 125.36 | 125.03 |
| Diluted Average Shares |
87,477%
126.11
|
0.144 | 125.69 | 125.36 | 125.03 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.74%
자본화:
|
볼륨(24시간):